124 related articles for article (PubMed ID: 27607362)
1. Bone mineral density is reduced by telmisartan in male spontaneously hypertensive rats.
Birocale AM; Medeiros AR; Ruffoni LD; Takayama L; de Oliveira JM; Nonaka KO; Pereira RM; Bissoli NS
Pharmacol Rep; 2016 Dec; 68(6):1149-1153. PubMed ID: 27607362
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan alleviates rosiglitazone-induced bone loss in ovariectomized spontaneous hypertensive rats.
Ma L; Ji JL; Ji H; Yu X; Ding LJ; Liu K; Li YQ
Bone; 2010 Jul; 47(1):5-11. PubMed ID: 20362079
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
Sato K; Yamashita T; Kurata T; Lukic V; Fukui Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1554-63. PubMed ID: 24780412
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats.
Fukui Y; Yamashita T; Kurata T; Sato K; Lukic V; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1545-53. PubMed ID: 24685992
[TBL] [Abstract][Full Text] [Related]
5. Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats.
Zhai Y; Yamashita T; Kurata T; Fukui Y; Sato K; Kono S; Liu W; Omote Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2350-61. PubMed ID: 25194744
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats.
Kishi T; Hirooka Y; Sunagawa K
J Cardiol; 2012 Dec; 60(6):489-94. PubMed ID: 22948091
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan in the treatment of hypertension.
Rosario BH; Hendra TJ
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):485-92. PubMed ID: 18433350
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan use in rats with preexisting osteoporotics bone disorders increases bone microarchitecture alterations via PPARγ.
Birocale AM; Ferreira de Melo A; Peixoto P; Costalonga Oliveira PW; Gonçalves Ruffoni LD; Takayama LM; Nogueira BV; Nonaka KO; Rodrigues Pereira RM; Martins de Oliveira J; Bissoli NS
Life Sci; 2019 Nov; 237():116890. PubMed ID: 31606379
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
[TBL] [Abstract][Full Text] [Related]
10. Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Kono S; Kurata T; Sato K; Omote Y; Hishikawa N; Yamashita T; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):537-47. PubMed ID: 25534368
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan prevents excess-salt-induced exacerbated (malignant) hypertension in spontaneously hypertensive rats.
Susic D; Fares H; Frohlich ED
J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):126-32. PubMed ID: 22927675
[TBL] [Abstract][Full Text] [Related]
13. Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
Dupuis F; Vincent JM; Limiñana P; Chillon JM; Capdeville-Atkinson C; Atkinson J
J Hypertens; 2010 Jul; 28(7):1566-73. PubMed ID: 20589978
[TBL] [Abstract][Full Text] [Related]
14. Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
Derosa G; Ragonesi PD; Mugellini A; Ciccarelli L; Fogari R
Hypertens Res; 2004 Jul; 27(7):457-64. PubMed ID: 15302981
[TBL] [Abstract][Full Text] [Related]
15. A pilot study for evaluation of the efficacy and safety of telmisartan in reducing microalbuminuria in hypertensive patients with type 2 diabetes mellitus.
Kulkarni RB; Kulkarni BN; Hariharan RS; Naikwadi A; Gawde A; Baliga V; Desai A
J Indian Med Assoc; 2005 Mar; 103(3):187-91. PubMed ID: 16173297
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan ameliorates inflammatory responses in SHR-SR after tMCAO.
Sato K; Yamashita T; Kurata T; Fukui Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014; 23(10):2511-2519. PubMed ID: 25245484
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation.
Omote Y; Deguchi K; Kurata T; Yamashita T; Sato K; Hishikawa N; Abe K
Curr Neurovasc Res; 2015; 12(1):91-7. PubMed ID: 25557372
[TBL] [Abstract][Full Text] [Related]
18. [Telmisartan effect's on remodelling bone markers in hypertensive patients].
Pérez-Castrillón JL; De Luis D; Inglada L; Olmos Martínez JM; Pinacho F; Conde R; González-Sagrado M; Dueñas-Laita A
Nutr Hosp; 2012; 27(1):276-80. PubMed ID: 22566334
[TBL] [Abstract][Full Text] [Related]
19. Strong improvement of apolipoprotein E/low-density lipoprotein receptor signals by telmisartan in poststroke spontaneously hypertensive stroke resistant.
Yamashita T; Zhai Y; Kurata T; Hishikawa N; Morimoto N; Ohta Y; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2240-9. PubMed ID: 25174563
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
Zhang Z; Li Z; Cao K; Fang D; Wang F; Bi G; Yang J; He Y; Wu J; Wei Y; Song X
J Hypertens; 2017 Jul; 35(7):1442-1456. PubMed ID: 28244896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
